Skip to main content
    M

    McKesson Corporation (MCK)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NYSE

    $1105.15
    +2.34 (+0.21%)

    Market Cap: $127.33B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    McKesson Corporation (MCK) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    McKesson (MCK) trades at 25.9x trailing earnings and 0.3x sales. Its P/E of 25.9x is above its 5-year median of 18.4x. Its forward P/E is 24.0x. The median P/E across 10 similar companies is 16.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 7.9% higher over the next year. Its free cash flow yield is 5.5%.

    MultipleValue
    P/E (trailing)25.9x
    Forward P/E24.0x
    Price to sales0.3x
    EV/EBITDA17.0x
    Price to FCF18.1x
    EV/FCF18.5x
    PEG1.9
    FCF yield5.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 105.6% above 12.6x and its P/S is 50.0% above 0.2x.

    MultipleCurrent5-year median10-year median
    P/E25.9x18.4x12.6x
    P/S0.3x0.2x0.2x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 8.3x in 2018 to 21.8x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$820.2921.8x0.3xN/A
    2024$569.9119.5x0.2xN/A
    2023$462.9816.3x0.2xN/A
    2022$375.1215.2x0.2xN/A
    2021$248.5710.8x0.2xN/A
    2020$173.9210.6x0.1xN/A
    2019$138.329.6x0.1x4.0x
    2018$110.478.3x0.1x2.3x
    2017$155.9512.4x0.2x2.8x
    2016$140.4511.1x0.2x4.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MCK

    What is MCK's forward P/E ratio?

    McKesson has a forward P/E ratio of 24.0x.

    Is MCK stock overvalued?

    GNG's valuation label for MCK is Fairly valued. Its P/E of 25.9x compares with a median of 16.7x across 10 similar companies.

    What is MCK's price to sales ratio?

    McKesson has a price to sales ratio of 0.3x.

    What is McKesson's average P/E ratio over 5 years?

    McKesson's median P/E over the last 5 years is 18.4x, from 60 month-end values through Oct 2026.

    What is MCK's PEG ratio?

    McKesson has a PEG ratio of 1.9.